Pfizer deal to make jabs in SA ‘a stepping stone to bigger things’
Biovac becomes the first company in Africa to manufacture mRNA Covid-19 vaccines in a deal Ramaphosa says will contribute to the continent’s health security
21 July 2021 - 16:26
UPDATED 21 July 2021 - 23:28
State-backed vaccine distributor Biovac Institute has reached an agreement with Pfizer and BioNTech to help manufacture 100-million doses of its mRNA Covid-19 vaccine a year for African countries.
It will be the first company in Africa to be involved in the production of an mRNA-based vaccine and joins a global network of more than 20 contractors involved in production of the Pfizer/BioNTech shot...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.